Axa’s PDL BioPharma, Inc. PDLI Stock Holding History

Axa’s Portfolio PDLI Stock Details PDLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-318,608	Closed	-$928K	–	1394
2020 Q3	$928K	Hold	318,608	–	–	﹤0.01%	953
2020 Q2	$927K	Sell	318,608 -40,500	-11%	-$118K	﹤0.01%	968
2020 Q1	$1.01M	Buy	359,108 +35,908	+11%	+$101K	0.01%	852
2019 Q4	$1.05M	Hold	323,200	–	–	﹤0.01%	882
2019 Q3	$698K	Buy	323,200 +250,000	+342%	+$540K	﹤0.01%	1045
2019 Q2	$230K	Buy	+73,200	New	+$230K	﹤0.01%	1209
2019 Q1	–	Sell	-20,700	Closed	-$60K	–	1444
2018 Q4	$60K	Hold	20,700	–	–	﹤0.01%	1286
2018 Q3	$54K	Sell	20,700 -130,200	-86%	-$340K	﹤0.01%	1323
2018 Q2	$353K	Sell	150,900 -135,600	-47%	-$317K	﹤0.01%	1199
2018 Q1	$842K	Sell	286,500 -52,300	-15%	-$154K	﹤0.01%	1043
2017 Q4	$928K	Buy	338,800 +318,100	+1,537%	+$871K	﹤0.01%	1023
2017 Q3	$70K	Buy	+20,700	New	+$70K	﹤0.01%	1303
2017 Q1	–	Sell	-131,000	Closed	-$278K	–	1365
2016 Q4	$278K	Sell	131,000 -157,800	-55%	-$335K	﹤0.01%	1158
2016 Q3	$967K	Sell	288,800 -17,600	-6%	-$58.9K	﹤0.01%	908
2016 Q2	$962K	Sell	306,400 -58,300	-16%	-$183K	﹤0.01%	886
2016 Q1	$1.21M	Sell	364,700 -190,000	-34%	-$632K	0.01%	837
2015 Q4	$1.96M	Sell	554,700 -15,600	-3%	-$55.2K	0.01%	771
2015 Q3	$2.87M	Buy	570,300 +26,400	+5%	+$133K	0.01%	703
2015 Q2	$3.5M	Sell	543,900 -24,300	-4%	-$156K	0.01%	660
2015 Q1	$4M	Buy	568,200 +43,500	+8%	+$306K	0.02%	653
2014 Q4	$4.05M	Sell	524,700 -378,300	-42%	-$2.92M	0.02%	612
2014 Q3	$6.75M	Buy	903,000 +262,500	+41%	+$1.96M	0.03%	462
2014 Q2	$6.2M	Buy	640,500 +12,500	+2%	+$121K	0.03%	497
2014 Q1	$5.22M	Buy	628,000 +275,300	+78%	+$2.29M	0.02%	511
2013 Q4	$2.98M	Buy	352,700 +80,900	+30%	+$683K	0.01%	677
2013 Q3	$2.17M	Buy	271,800 +24,500	+10%	+$195K	0.01%	722
2013 Q2	$1.91M	Buy	+247,300	New	+$1.91M	0.01%	717